Cantor Fitzgerald Starts Biogen (BIIB) at Neutral
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $208.45 +3.29%
Rating Summary:
27 Buy, 16 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 23
Rating Summary:
27 Buy, 16 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 23
Join SI Premium – FREE
Cantor Fitzgerald initiated coverage on Biogen (NASDAQ: BIIB) with a Neutral rating.
For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.
Shares of Biogen closed at $286.25 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) PT Raised to $251 at H.C. Wainwright
- Guggenheim Resumes argenx SE (ARGX) at Buy
- Biogen (BIIB) PT Lowered to $240 at RBC Capital
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
